Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEAYA Biosciences, Inc. Director's Dealing 2021

Oct 27, 2021

31547_dirs_2021-10-27_724727b8-0513-464e-a54e-5511c798af2f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEAYA Biosciences, Inc. (IDYA)
CIK: 0001676725
Period of Report: 2021-10-25

Reporting Person: WHITE MICHAEL ANTHONY (SVP, Chief Scientific Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-25 Stock Option (right to buy) $22.01 A 200000 Acquired 2031-10-24 Common Stock (200000) Direct

Footnotes

F1: 25% of the shares subject to the option vest on the first anniversary measured from October 25, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.